Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic, pharmacokinetic and pharmacodynamic study of dapagliflozin in healthy and obese adults
KCT0007864Phase 4Not yet recruiting
- Sponsor
- Ministry of Science and ICT
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Ministry of Science and ICT. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
dapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on KCT0007864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007864.